Tuesday, November 11, 2025

CATEGORY

Pharmacoeconomics

British Columbia’s New Melanoma Policy: Costs Rise Without Population-Wide Mortality Benefit

British Columbia has introduced a groundbreaking cancer control policy aiming to reimburse multi-gene panel testing and pembrolizumab therapy for patients dealing with metastatic melanoma....

Cost-Effectiveness of CDK4/6 Inhibitors in Advanced Breast Cancer: Insights from the SONIA Trial

The fight against advanced breast cancer continues to challenge oncologists with decisions about optimal treatment pathways. The balance between efficacy and economic sustainability is...

MS-COM Model Shows Strong Predictive Power for Obesity Management Outcomes

As obesity continues to pose significant health and economic challenges globally, the MicroSimulation Core Obesity Model (MS-COM) has emerged as a crucial tool for...

Novel Approach Enhances Understanding of Caregiving Impact in Economic Evaluations

In the realm of pharmacoeconomics, the intricate relationship between patients and their caregivers often goes underappreciated, yet it plays a crucial role in real-world...

Palopegteriparatide Proves Effective for Chronic Hypoparathyroidism in New Study

Chronic hypoparathyroidism, a rare but debilitating endocrine disorder, has left patients yearning for more effective treatment options. A new study sheds light on a...

Elobixibat Shows Superior Cost-Effectiveness in Managing Chronic Idiopathic Constipation

With modern lifestyles posing a significant risk for chronic idiopathic constipation (CIC), managing not only symptoms but also the overall economic and personal impact...

Tralokinumab Shows Superior Cost-Effectiveness Against Dupilumab in Atopic Dermatitis Treatment

Chronic skin conditions like atopic dermatitis (AD) can heavily impact the quality of life, necessitating effective and economically viable treatments. Patients with moderate-to-severe AD...

Automated RBCX Proves Vital in Managing Sickle Cell Disease

In the global battle against sickle cell disease (SCD), a condition affecting millions, innovative approaches to treatment are continually being explored. The latest study...

Lidocaine with Epinephrine Offers Best Value in Managing Irreversible Pulpitis

Pulpitis, a key challenge in dental care, demands reliable solutions that balance efficacy with cost. As dentists continuously seek optimal anesthetics for managing symptomatic...

NICE Embraces Comprehensive Carer HRQoL in Health Technology Assessments

In the evolving landscape of health technology assessments, the National Institute for Health and Care Excellence (NICE) has increasingly prioritized the inclusion of carer...

Survey Shows High Patient Satisfaction with Pharmacist-Led Decision Process in IBD Treatment

In the realm of healthcare for inflammatory bowel disease (IBD) patients, the emergence of biologics and Janus kinase inhibitors presents a paradigm shift in...

Study Finds HPV Vaccination for GBMSM Aged 45 and Under Cost-Saving

The Advisory Committee on Immunization Practices (ACIP) has long advocated for HPV vaccination beginning in pre-adolescence. Yet, navigating vaccination for adults remains a pivotal...

UK Public Values Health States with Enhanced FACT-8D Analysis

The pursuit of understanding how individuals value different health outcomes has seen significant progress with the latest development of a value set using the...

U.S. Drug Pricing: Inside the Cost and Value Conundrum

The pursuit of equitable healthcare has driven significant reforms in various areas of policy, with drug pricing taking center stage in recent years. The...

Prevention Strategies Gain Momentum as Economic Value is Reassessed

The critical impact of prevention in healthcare garners global consensus, yet the allocation of resources to preventive measures remains minimal. This gap presents both...

Latest news